Classic e-Delphi survey to provide national consensus and establish priorities with regards to the factors that promote the implementation and continued development of non-medical prescribing within health services in Wales by Courtenay, Molly et al.
1Courtenay M, et al. BMJ Open 2018;8:e024161. doi:10.1136/bmjopen-2018-024161
Open access 
Classic e-Delphi survey to provide 
national consensus and establish 
priorities with regards to the factors that 
promote the implementation and 
continued development of non-medical 
prescribing within health services 
in Wales
Molly Courtenay,1 Rhian Deslandes,2 Gail Harries-Huntley,3 Karen Hodson,4 
Gary Morris5,6
To cite: Courtenay M, 
Deslandes R, Harries-Huntley G, 
et al.  Classic e-Delphi survey to 
provide national consensus and 
establish priorities with regards 
to the factors that promote the 
implementation and continued 
development of non-medical 
prescribing within health 
services in Wales. BMJ Open 
2018;8:e024161. doi:10.1136/
bmjopen-2018-024161
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
024161). 
Received 12 May 2018
Revised 9 July 2018
Accepted 18 August 2018
For numbered affiliations see 
end of article.
Correspondence to
Professor Molly Courtenay;  
 courtenaym@ cardiff. ac. uk
Research
© Author(s) (or their 
employer(s)) 2018. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Objective To provide national consensus and establish 
priorities with regards to the factors that promote the 
implementation and continued development of non-
medical prescribing within health services.
Design Classic e-Delphi survey.
setting National study in Wales.
Participants Pharmacists, nurses and allied health 
professionals with the independent/supplementary 
prescribing qualification.
results A total of 55 non-medical prescribers agreed 
to become members of the expert panel of whom 42 
(76%) completed the round 1 questionnaire, 40/42 
(95%) completed round 2 and 34/40 (85%) responded 
to round 3. Twenty-one statements were developed, and 
consensus was achieved on nine factors representing 
those necessary for the successful implementation of 
non-medical prescribing and five representing actions 
required for its continued development. Strategic fit 
between non-medical prescribing and existing service 
provision, organisation preparedness, visible benefits, good 
managerial and team support, and a clear differentiation of 
roles were each important influences.
Conclusion Given the high degree of consensus, this 
list of factors and actions should provide guidance to 
managers and commissioners of services wishing to 
initiate or extend non-medical prescribing. This information 
should be considered internationally by other countries 
outside of the UK wishing to implement prescribing by 
non-medical healthcare professionals.
The aim of this study was to provide national 
consensus and establish priorities with 
regards to the factors that promote the 
implementation and continued development 
of non-medical prescribing within health 
services in Wales. 
IntrODuCtIOn  
Globally, healthcare systems are imple-
menting strategies, including expanded 
scopes of practice for healthcare profes-
sionals, to improve healthcare delivery. One 
such example is the expanded scope of 
practice by non-medical healthcare profes-
sionals (including nurses, pharmacists 
and allied health professionals (AHPs)) to 
include prescribing capability. Nurses and 
pharmacists in several countries including 
Canada, Sweden, New Zealand, the Neth-
erlands, Ireland, Australia, USA and UK 
can now prescribe medicines.1–4 Faster and 
more efficient access to medicines, a need to 
address doctor shortages, the development 
of advanced practitioner roles and more 
strengths and limitations of this study
 ► Although our survey included responses from the 
full range of non-medical healthcare professionals 
who can prescribe medicines, only small numbers 
of respondents were pharmacists and allied health 
professionals, and our results may therefore reflect 
a nursing perspective not applicable to all non-med-
ical prescribers.
 ► Most expert panel members worked in secondary 
care and in-hospital or outpatient services and so 
may not be reflective of the views of non-medical 
prescribers working in other settings/services.
 ► We acknowledge that for care to be patient centred, 
patients should participate in healthcare research; 
however, patients were not included as expert panel 
members.
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effective use of healthcare professionals’ knowledge and 
skills are each drivers for this role.1
In the UK, appropriately qualified registered nurses, 
pharmacists and AHPs can prescribe any medicine within 
their area of competence both independently (ie, respon-
sible for the assessment, diagnosis and decisions about 
the clinical management required in patients with diag-
nosed or undiagnosed conditions)5 or via supplemen-
tary prescribing.6 Supplementary prescribing comprises 
a written agreement, between the doctor, patient and 
supplementary prescriber, on the medicines the supple-
mentary prescriber can prescribe.
The model of prescribing training in the UK, which is 
government funded, typically 6 months in duration, and 
only requiring applicants to be at degree level,7 has facili-
tated the rise in non-medical prescriber (NMP) numbers 
over the last 5 years.8 Around 32 000 nurses, 4000 phar-
macists and 1000 AHPs and optometrists have indepen-
dent and supplementary prescribing capability.8 This 
represents about 5% of the UK nursing workforce, 7% of 
the pharmacy workforce and between 1% and 2% of the 
AHP workforce eligible to prescribe. These prescribers 
work in a variety of healthcare settings (including primary 
and secondary care) and prescribe medicines across a 
broad range of therapeutic areas.9–11 NMPs are safe,10 12 
clinical and patient reported outcomes are comparable 
with medical prescribers13 14 and stakeholders are satisfied 
reporting increased accessibility of services.15 16 Further-
more, findings of an economic evaluation of NMPs in the 
North West of England17 identified that in terms of impact 
on patient outcomes, each of the 1566 NMP participants 
contributed an average added value of nearly £1500 over 
a 1-month period, that is, together a total of £2.7 million 
for the month.
Despite this evidence, national evaluations report that 
non-medical prescribing has been implemented inconsis-
tently across Clinical Commissioning Groups and health 
boards (HBs) within the UK, and there is great variance 
with regards to the numbers of prescribers working 
within HBs/National Health Service Trusts, the numbers 
working within healthcare teams and the range of services 
and roles in which NMPs work.9 10 18 19 
These variations may lead to significant differences in 
the experiences of service users and have a differential 
effect on the workforce, with some non-medical health-
care professionals expected to integrate prescribing 
into their clinical practice in some organisations, while 
prescribing remains the domain of doctors in others.
There is some evidence available that has explored the 
factors that influence the use of prescribing by specific 
healthcare professional groups. For example, strong rela-
tionships with other prescribers20 21 and the importance 
of trust in these relationships22 have been reported to 
influence the integration of prescribing into practice by 
nurses. There is also evidence available that has examined 
the implementation of prescribing by specific health-
care professional groups working in certain services 
and settings. For example, nurse prescribing has been 
reported to be successfully implemented in diabetes 
service delivery because of the established roles nurses 
already have within diabetes teams and the strong collab-
orative working that is already in place.23 Pharmacists 
have described how implementation is smoother when 
prescribing is introduced into pre-existing structures 
and care arrangements, thus facilitating tasks already 
performed prior to its implementation.24 25 However, it 
would be a useful exercise to identify the key factors that 
promote the implementation of NMP that can be applied 
to all NMP groups and the different services and settings 
within which they work. This would provide useful guid-
ance to those wishing to initiate or extend NMP and help 
to promote consistency across services.
The aim of this study was to provide national consensus 
and establish priorities with regards to the factors that 
promote the implementation and continued develop-
ment of non-medical prescribing within health services 
in Wales.
MethODs
Design
Where there is a dearth of research evidence and a desire 
to reach consensus, formal or structured methods are 
commonly used.26 A commonly used formal consensus 
method is the Delphi technique. This technique uses 
rounds of questionnaires to collect data and achieve 
group consensus.27
A classic Delphi survey28 29 was adopted whereby round 
1 of the Delphi survey involved item generation, that is, 
the first questionnaire contained open-ended questions 
inviting participants to provide their views on the factors 
that promote the implementation and development of 
non-medical prescribing within health services in Wales 
from which subsequent questionnaires were developed.
recruitment
Experts, as opposed to a random sample representative of 
the target population, are employed as panel members in 
the Delphi technique, and it is recommended that explicit 
criteria are used to select panel members.30 ‘Expert’ in 
this study was defined as a pharmacist, nurse or AHP 
with the independent and supplementary prescribing 
qualification.
Purposive sampling was used to recruit a panel reflecting 
the range of non-medical healthcare professionals able to 
prescribe medicines using independent and supplemen-
tary prescribing. To ensure the full range of these health-
care professionals were included on the panel and that 
they were representative of independent/supplementary 
prescribers across Wales, all participants who had recently 
completed a national non-medical prescribing survey 
(n=379)11 were invited to contact the researchers if they 
were interested in becoming an expert member of the 
Delphi panel.
There is no agreement within the literature as to 
the best number of participants to include in a Delphi 
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survey.27 Although a large expert panel is recommended31 
for heterogenous samples, it is unclear what constitutes 
large. Therefore, we included all NMPs who were keen to 
take part and fulfilled our definition of ‘expert’. Seventy 
NMPs expressed an initial interest to participate. Each 
was given a Participant Information Sheet and provided 
with the opportunity to address any queries they may have 
had with a researcher. Fifty-five NMPs agreed to take part. 
Return of completed questionnaires provided implied 
consent to participate
Data collection
The survey was conducted across three rounds. Bristol 
Online Survey—a tool for creating web surveys—was used 
to develop each round of the online questionnaire survey. 
A link to each survey was distributed via email to all partic-
ipants followed by two reminder emails, at 1 week inter-
vals, per survey round. Data collection took place between 
October 2016 and December 2016.
Round 1: elicitation of the factors and actions required to promote 
the implementation and continued development of non-medical 
prescribing in service delivery
Participants were asked to provide their views on the 
factors that promote the implementation and continued 
development of non-medical prescribing within health 
services in Wales. Participants were able to provide as 
Table 1 Non-medical prescribers who responded to each 
round
NMP
Round 1
n=42
Round 2
n=40
Round 3
n=34
n % n % n %
Nurse 35 63.6 33 60 28 51.0
Pharmacist 4 7.3 4 7.3 3 5.5
Physiotherapist 2 3.6 2 3.6 2 3.6
Radiographer 1 1.9 1 1.9 1 1.9
NMP, non-medical prescriber.
Figure 1 Summary of the Delphi process.
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much information as they wished within the free text 
space provided.
Refining factors and actions
The data were analysed by an experienced qualitative 
researcher using thematic analysis.32 Data were read, 
and words, phrases and sentences relating to the imple-
mentation and continued development of non-medical 
prescribing were identified. This information was then 
condensed and grouped into themes. This process was 
supported by the use of NVivo 10 qualitative data analysis 
software package. To cross-check data analysis and ensure 
data quality, consistency in approach and transparency 
of analytical decision making, 50% of the data were read 
and coded independently by a second experienced qual-
itative researcher. Differences in interpretation were 
resolved through discussion between the two researchers 
and the wider research team. A number of statements 
representing each theme were then developed.
Round 2: building consensus
An email was sent to members of the expert panel inviting 
them to participate in round 2 of the Delphi process. 
In this round, NMPs were asked to rate how much they 
agreed or disagreed with each of the statements devel-
oped in round 1, using a 5-point Likert scale (1=strongly 
disagree to 5=strongly agree). Median scores and IQRs 
were calculated for responses to each statement to define 
at which point on the Likert scale 50% of the answers fell 
above and below.
IQRs that form the distance between the 25th and 
75th percentiles were used to represent the spread of 
the data and to assess the level of consensus per ques-
tion. Responses where the median was greater than or 
equal to 4 (high level of agreement that the statement is 
important) with a small IQR (less than or equal to 1.5) 
were considered important statements that had reached 
consensus. Those with a median score less than or equal 
to 3.5, with a small IQR (less than or equal to 1.5), were 
considered to have reached consensus on a lack of 
Table 2 Demographic data of participants in round one 
survey
Round 1 
(n=42), n (%)
Role*
  Specialist nurse 21 (50)
  Community nurse 3 (7)
  General practice nurse 9 (21)
  Senior clinical nurse 2 (5)
  Pharmacist 4 (10)
  Physiotherapist 2 (5)
  Radiographer 1 (2)
Care setting
  Primary 6 (14)
  Secondary 20 (48)
  Tertiary 4 (10)
  Community/intermediate 3 (7)
  More than one of the above 9 (21)
Service provided
  Hospital inpatient 9 (21)
  Hospital outpatient 10 (24)
  General practice 4 (10)
  Out of hours 1 (2%)
  Community/intermediate care 3 (7)
  More than one of the above 15 (36)
Prescribing qualification
  Nurse independent/supplementary 
prescriber
35 (83)
  Pharmacist independent/supplementary 
prescriber
4 (10)
  Physiotherapist supplementary prescriber 1 (2)
  Physiotherapist independent/
supplementary prescriber
1 (2)
  Radiographer supplementary prescriber 1 (2)
*Specialist nurses: (clinical nurse specialist, specialist 
nurse practitioner and nurse clinician); community nurses 
(team lead); general practice nurses (advanced nurse 
practitioner, practice nurses and nurse practitioners); senior 
clinical nurse (ward manager). Pharmacist: (senior clinical 
pharmacist, advanced practitioner and medicines management 
pharmacist); physiotherapist: (clinical specialist and advanced 
practitioner); radiographer.
box 1 Factors that promote the implementation of non-
medical prescribing
 ► Team members, managers and those working in senior roles within 
the health board/trust/general practice need to recognise non-medi-
cal prescribing as a positive contributor to improve service efficiency.
 ► The successful implementation of non-medical prescribing requires 
that organisations are ready and prepared for this role, that is, struc-
tures and processes are in place that enable prescribing.
 ► It is important that the value of non-medical prescribing is demon-
strated through patient satisfaction.
 ► Healthcare teams, managers and those responsible for service re-
design and workforce planning need to understand the non-medical 
prescribing role and its potential.
 ► Both management and team support are required for the non-med-
ical prescribing role to be fully implemented.
 ► It is important that there is a strategic fit between non-medical 
prescribing and existing service provision so that non-medical pre-
scribing is seen as enhancing service efficiency rather than altering 
the structural organisation of care.
 ► Good interprofessional relationships are required in order to pro-
mote the necessary supportive culture for the acceptance of the 
non-medical prescribing role.
 ► Clinical supervision is essential for the successful implementation of 
non-medical prescribing.
 ► Continuing professional development is vital for the successful im-
plementation of non-medical prescribing.
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importance. All important statements that had reached 
consensus were taken forward to the third round.
Round 3: reaching consensus on priorities
In the final round, statements were randomly listed, 
and participants were asked to rank how much of a 
priority each statement was from 1 to 10 (where 1 was 
the most important and 10 was the least important). 
Participants were asked to use each number only once, 
leaving those that they felt were not so important blank. 
Responses were inversely scored and collated. Priorities 
were defined as those factors receiving the highest total 
scores.
Patient and public involvement
Patients were not involved in the development of the 
research question, outcome measures, design of the study 
or recruitment to, and conduct of, the study.
results
A total of 55 NMPs agreed to become members of the 
expert panel of whom 42 (76%) completed round 1 ques-
tionnaire, 40/42 (95%) completed round 2 and 34/40 
(85%) responded to round 3. Table 1 provides a descrip-
tion of the different types of NMPs who responded to 
each round. Figure 1 provides a summary of each round 
of the Delphi process.
round 1
Forty-two (76%) participants responded to the initial 
survey. Most of these participants were nurses (see 
table 1).
Most respondents (20% or 47%) worked in secondary 
care and provided hospital in-patient or out-patient 
services. The demographic characteristics of these partic-
ipants are described in table 2.
Twenty-one statements were developed, that is, nine 
statements representing the factors that promote the 
implementation of non-medical prescribing, and 12 
statements representing the actions required in order to 
continue its development (see box 1 and 2).
box 2 Actions required for the continued development of 
non-medical prescribing across health services
 ► Staff involved in strategic planning and policy development need to 
provide non-medical prescribers (NMPs) with timely, relevant, ad-
equate and up-to-date information on legislation, policy and good 
practice surrounding prescribing and medicines management.
 ► NMPs should be involved in the development of prescribing and 
medicines management policies and guidelines.
 ► A consistent strategic approach to the implementation and progres-
sion of non-medical prescribing (ie, workforce planning, selection of 
candidates for training, provision of clinical supervision, continuing 
professional development (CPD) and organisational preparation for 
the role) is required.
 ► There is a need for improved access to clinical supervision.
 ► There is a need for improved peer support.
 ► There is a need for improved CPD.
 ► The non-medical prescribing qualification should be a job specifica-
tion for certain roles (eg, advanced practitioner) and should not be 
lower than a Band 7.
 ► A proactive approach to succession planning needs to be adopted.
 ► Frontline practitioner prescribers in senior roles need to be involved 
in service redesign and workforce planning.
 ► Increased funding should be available for those wishing to under-
take non-medical prescribing training.
 ► Study leave should be available for those wishing to undertake 
non-medical prescribing training.
 ► Clinical governance systems within which NMPs work need to be 
improved.
Table 3 Factors that promote the implementation of non-medical prescribing
Median IQR
Team members, managers and those working in senior roles within the health board/trust/general practice 
need to recognise non-medical prescribing as a positive contributor to improve service efficiency.
4.0 0.0
Healthcare teams, managers and those responsible for service redesign and workforce planning need to 
understand the non-medical prescribing role and its potential.
4.0 0.0
The successful implementation of non-medical prescribing requires that organisations are ready and prepared 
for this role that is, structures and processes are in place that enable prescribing.
4.0 0.5
Both management and team support are required for the non-medical prescribing role to be fully 
implemented.
4.0 1.0
It is important that there is a strategic fit between non-medical prescribing and existing service provision so 
that it is seen as enhancing service efficiency rather than altering the structural organisation of care.
4.0 1.0
Good interprofessional relationships are required in order to promote the necessary supportive culture for the 
acceptance of the non-medical prescribing role.
4.0 1.0
Clinical supervision is essential for the successful implementation of non-medical prescribing. 4.0 1.0
Continuing professional development is vital for the successful implementation of non-medical prescribing. 4.0 1.0
It is important that the value of non-medical prescribing is demonstrated through patient satisfaction. 4.0 1.5
*Shaded areas signify the factors that promote the implementation of non-medical prescribing within health services in Wales for which there 
was high level of agreement among panel members.
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round 2
Forty out of 42 (95%) participants responded to the 
second round. See tables 3 and 4 for a description of the 
median scores and IQRs for each of the statements.
Participant responses showed a high level of impor-
tance across 14 of the statements (nine representing the 
factors that promote the implementation of non-medical 
prescribing and five statements representing the actions 
required in order to continue its development); each state-
ment having a median greater than or equal to four and 
a IQR less than or equal to 1.5. There was consensus on a 
lack of importance across seven statements representing 
the actions required for the continued development of 
non-medical prescribing, that is, each statement had a 
score less than or equal to 3.5 and an IQR less than or 
equal to 1.5.
round 3
Thirty-four (85%) participants responded to the third 
round. Statements representing factors that promote 
the implementation and continued development of 
non-medical prescribing are shown in priority order in 
tables 5 and 6.
Table 4 Actions required for the continued development of non-medical prescribing across health services
Actions required for the continued development of non-medical prescribing across health services.
Staff involved in strategic planning and policy development need to provide NMPs with timely, relevant, 
adequate and up-to-date information on legislation, policy and good practice surrounding prescribing and 
medicines management.
3.0 1.0
NMPs should be involved in the development of prescribing and medicines management policies and guidelines. 4.0 1.0
A consistent strategic approach to the implementation and progression of non-medical prescribing (ie, 
workforce planning, selection of candidates for training, provision of clinical supervision, CPD and organisational 
preparation for the role) is required.
4.0 1.0
Clinical governance systems within which NMPs work need to be improved. 3.0 1.0
There is a need for improved peer support. 3.0 1.0
There is a need for improved access to clinical supervision. 3.0 1.25
There is a need for improved continuing professional development. 3.0 1.25
The non-medical prescribing qualification should be a job specification for certain roles (eg, advanced 
practitioner) and should not be lower than a Band 7.
4.0 1.0
A proactive approach to succession planning needs to be adopted. 4.0 1.0
Increased funding should be available for those wishing to undertake non-medical prescribing training. 3.0 1.5
Frontline practitioner prescribers in senior roles need to be involved in service redesign and workforce planning. 3.5 1.0
Study leave should be available for those wishing to undertake non-medical prescribing training. 4.0 1.0
*Shaded areas signify the actions required for the continued development of non-medical prescribing within health services in Wales for 
which there was high level of agreement among panel members.
CPD, continuing professional development.
Table 5 Factors that promote the implementation of non-medical prescribing in priority order
Rank Factor
1 Clinical supervision is essential for the successful implementation of non-medical prescribing.
2 Continuing professional development is vital for the successful implementation of non-medical prescribing.
3 It is important that the value of non-medical prescribing is demonstrated through patient satisfaction.
4 Good interprofessional relationships are required in order to promote the necessary supportive culture for the 
acceptance of the NMP role.
5 It is important that there is a strategic fit between non-medical prescribing and existing service provision so that it is 
seen as enhancing service efficiency rather than altering the structural organisation of care.
6 Both management and team support are required for the NMP role to be fully implemented.
7 Healthcare teams, managers and those responsible for service redesign and workforce planning need to understand 
the NMP role and its potential.
8 The successful implementation of non-medical prescribing requires that organisations are ready and prepared for this 
role, that is, structures and processes are in place that enable prescribing.
9 Team members, managers and those working in senior roles within the health board/trust/general practice need to 
recognise non-medical prescribing as a positive contributor to improve service efficiency.
NMP, non-medical prescriber.
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DIsCussIOn
statement of principal findings
The aim of this study was to provide national consensus 
and establish priorities with regards to the factors that 
promote the implementation and continued develop-
ment of non-medical prescribing within health services. A 
classic Delphi survey was adopted whereby round 1 of the 
survey rounds involved item generation, and this enabled 
panellists to reach a consensus, with consistent high levels 
of agreement reached, on 14 statements. Confidence 
in consensus resulted in a list of factors and actions, in 
priority order, that promote the implementation and 
continued development of non-medical prescribing 
within health services in Wales.
strengths and weaknesses
The main strength of the work is that it is based on 
responses from a national panel of defined experts, had 
a good response rate and provides information on the 
factors that promote the implementation and continued 
development of non-medical prescribing within health 
services. However, some limitations also need to be 
recognised. First, the composition of the expert panel, 
with most experts being nurses, and only small numbers 
of respondents representing pharmacists and AHPs 
(ie, physiotherapists and podiatrists). Our results may 
therefore reflect a nursing perspective not applicable 
to all NMPs. Second, we could have included patients as 
members of the expert panel. We acknowledge that for 
care to be patient centred, patients need to participate in 
the research that informs healthcare decisions, however, 
given resource constraints and the, problems associ-
ated with large heterogenous samples (ie, difficulties 
surrounding data collection/analysis, reaching consensus 
and verifying results),28 only NMPs were included as panel 
members. Third, perceptions of factors that promote 
the implementation and development of non-medical 
prescribing may have been influenced by the setting/
services in which respondents worked. Most expert panel 
members worked in secondary care and hospital inpa-
tient or outpatient services and so may not reflect the 
views of NMPs working in other settings/services. Fourth, 
it is important to recognise that the results of Delphi 
studies are ‘group consensus’ and not necessarily ‘best’, 
‘expert’ or ‘correct’ results.29 Despite these limitations, 
this study has provided a list of factors, in priority order, 
that promote the implementation and continued devel-
opment of non-medical prescribing within health services 
in Wales.
Comparison with other studies
The extent to which there is a strategic fit between 
non-medical prescribing and existing service provision, 
and that non-medical prescribing is seen as enhancing 
service efficiency rather than altering the structural 
organisation of care, was viewed as a key factor that 
promoted its implementation. This aligns with research 
that has explored innovations in health services,33 34 inno-
vations more likely to be adopted where there are clear 
advantages and few barriers to its adoption, and supports 
the findings of earlier studies in which researchers have 
investigated nurse and pharmacist prescribing.23–25 35–37
Researchers exploring prescribing by nurses working in 
diabetes23 and dermatology37 services delivery reported 
that pre-existing and established roles (including their 
involvement in medicines management activities such 
as medicines reviews and running clinics) facilitated the 
implementation of prescribing. Prescribing was viewed 
as improving service efficiency without the need to alter 
existing arrangements or roles. Similarly, prescribing by 
pharmacists24 has been reported to be successful where 
it helped them complete tasks to which they already 
contributed or performed in part. For example, prior 
to prescribing, medication was reported to be provided 
without a prescription. The ability to issue a prescription 
legitimised this practice and facilitated the completion of 
the task.24
The extent to which organisations are ready and 
prepared for non-medical prescribing was another 
important factor reported to promote its implemen-
tation. Processes such as access to clinical supervision 
and continuing professional development (CPD) were 
reported to be important influences. The availability of 
study leave to undertake prescribing training, the involve-
ment of NMPs in the development of prescribing and 
medicines management policies and guidelines and a 
consistent strategic approach to the implementation of 
non-medical prescribing were each reported actions 
required for its continued development in Wales. Our 
findings are consistent with research reporting on a 
Table 6 Actions required for the continued development of non-medical prescribing in priority order
Rank Action
1 A proactive approach to succession planning needs to be adopted.
2 NMPs should be involved in the development of prescribing and medicines management policies and guidelines.
3 Study leave should be available for those wishing to undertake non-medical prescribing training.
4 The non-medical prescribing qualification should be a job specification for certain roles (eg, advanced practitioner) and 
should not be lower than a Band 7.
5 A consistent strategic approach to the implementation and progression of non-medical prescribing (ie, workforce 
planning, selection of candidates for training, provision of clinical supervision, continuing professional development 
and organisational preparation for the role) is required.
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national evaluation of physiotherapist and podiatrist 
prescribers.38 These researchers reported that in order to 
embed prescribing, there is a need for a clear NMP strategy 
at an organisational level. The findings also concur with 
research involving nurse and pharmacist prescribers. As 
with the findings in this study, pharmacists have been 
found to be more likely to prescribe when they have 
access to clinical information, and up-to-date prescribing 
policies were in place.39 Similarly, access to CPD has been 
reported to encourage prescribing by nurses.21 40 Further-
more, where prescribing has been introduced to nurses 
working in well-established roles, this has been reported 
to have helped its successful implementation, as condi-
tions such as CPD and access to clinical supervision are 
already in existence.23
Visible benefits were reported to be another important 
influence on the implementation of prescribing. Benefits 
included patient satisfaction and the need for non-med-
ical prescribing to be recognised as a positive contributor 
to enhance service efficiency. Similarly, visible benefits 
including perceived improvements to patient care have 
been reported to facilitate the adoption of prescribing 
by nurses,36 and convenience for both patients and phar-
macists have been reported to encourage prescribing by 
pharmacists.24
Good managerial and team support, good interprofes-
sional relations and a clear differentiation of roles (the 
non-medical prescribing qualification was viewed as a job 
specification for advanced practitioner roles) were also 
other important influences. This is consistent with find-
ings of previous research in which a receptive context 
for change, that is, a history of collaborative working, 
was reported to have paved the way for good relations 
between nurse prescribers and doctors, with the promo-
tion of the supportive culture necessary for acceptance 
of the prescribing role.23 More recently, the influence of 
professional relationships on the prescribing boundaries 
of nurses, and the integration of prescribing by nurses 
into practice, has been highlighted.22 Similarly, phar-
macists have also reported that the nature and extent 
of pharmacist prescriber relations with physicians has a 
substantial influence on whether or not they prescribe, 
many pharmacists expressing a reluctance to prescribe 
when they believed the physician was unsupportive.39 It is 
interesting to note that the prescribing qualification was 
seen as a job specification for advanced practitioner roles 
and viewed as no lower than a band 7. New UK standards 
for prescribing education for nurses will enable first-level 
registered nurses with only 1 year qualified experience 
(and so likely to be lower than a band 7) to access the 
prescribing programme.41
Meaning of the study: possible explanations and implications 
for clinicians and policy makers
It is evident that non-medical prescribing has been imple-
mented inconsistently across health services in Wales.11 
The findings of this study provide guidance to managers 
and commissioners of services wishing to implement 
non-medical prescribing in new areas of practice, or,fur-
ther develop services already in existence. This will help 
to promote consistency across services. The findings also 
provide guidance for countries outside of the UK wishing 
to implement non-medical prescribing, although their 
origin from a UK perspective means there is a need for 
adaptation to other healthcare systems.
unanswered questions and future research
Research designed to test and refine the factors identified 
by expert members would be helpful. Testing these factors 
in different contexts and across different non-medical 
prescriber groups would also be useful, as barriers and 
facilitators to non-medical prescribing implementation 
may differ in emphasis across services and professions.
COnClusIOn
Given the high degree of consensus, this list of factors 
and actions should provide guidance to managers and 
commissioners of services wishing to initiate or extend 
non-medical prescribing. This information should be 
considered internationally by other countries outside of 
the UK wishing to implement prescribing by non-medical 
healthcare professionals.
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